Literature DB >> 85987

Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic-pituitary-adrenal axis activity.

M A Schlesser, G Winokur, B M Sherman.   

Abstract

Serum-cortisol response to the 1 mg overnight dexamethasone suppression test was investigated in 86 patients with unipolar primary depressive illness and 80 non-depressed controls (45 with mania and 35 with schizophrenia). The depressed patients were assigned to one of three genetic subtypes according to the family psychiatric history. Resistance to suppression of serum-cortisol by dexamethasone was found in 37 of 86 (43%) depressives and none of the 80 controls. Non-suppression distinguished the three genetic subtypes of depression, being found in 23 of 28 (82%) patients with familial pure depressive disease (F.P.D.D.), 13 of 35 (37%) patients with sporadic depressive disease (S.D.D.), and 1 of 23 (4%) patients with depression spectrum disease (D.S.D.). The three genetic subtypes were further distinguished by the age of onset, with S.D.D. the oldest, and by the number of previous depressive episodes, with F.P.D.D. the most. Severity of depression did not separate the three subtypes. This is the first report of a distinct neuroendocrine abnormality which supports an objectively defined classification of unipolar primary depressive illness. It is suggested that unipolar primary depressive illness is three or more separate illnesses, each with a potentially distinctive mode of inheritance, pathophysiology, neurochemistry, clinical course, and treatment response.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 85987     DOI: 10.1016/s0140-6736(79)91203-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  Depressive states in 11 psychiatrically hospitalized preschoolers: investigation and review.

Authors:  M B Doherty; P A Rosenthal
Journal:  Child Psychiatry Hum Dev       Date:  1988

Review 2.  Current antidepressant drugs: their clinical use.

Authors:  L E Hollister
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

3.  The dexamethasone suppression test in dementia.

Authors:  G Magni; F Schifano; D De Leo; O Zangaglia
Journal:  Ital J Neurol Sci       Date:  1987-04

4.  The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.

Authors:  H J Möller; W Kissling; P Bottermann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

5.  Rostral anterior cingulate cortex volume correlates with depressed mood in normal healthy children.

Authors:  Aaron D Boes; Laurie M McCormick; William H Coryell; Peg Nopoulos
Journal:  Biol Psychiatry       Date:  2007-10-03       Impact factor: 13.382

6.  Biological classification of depressive illness.

Authors:  A Coppen; K Wood
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

7.  [Dexamethasone suppression test: a biologic marker of endogenous depression?].

Authors:  M Berger; H E Klein
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.